跳至主要内容
临床试验/NCT02394392
NCT02394392已完成不适用

Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient: a Prospective, Cross-sectional and Open-label 8 Week Switching Study

Boryung Pharmaceutical Co., Ltd1 个研究点 分布在 1 个国家目标入组 12,691 人开始时间: 2014年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12,691
试验地点
1
主要终点
quality of life questionnaire for hypertension

研究概览

简要总结

  1. Investigate the clinical characteristics, medication satisfaction and quality of life of anti-hypertensive drugs in Korean hypertensive patients
  2. Observe the changes of medication satisfaction and compliance in patients after switchting to Fimasartan

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Over 20 years old
  • Essential hypertensive patients who taking anti-hypertensive drugs during previous 1 month
  • Patients does not taking Fimasartan
  • Patient's medication satisfaction score under 4

排除标准

  • Patients with secondary hypertension
  • Patients with orthostatic hypotension who has sign and symptom
  • Patients with known severe or malignancy retinopathy
  • Patients with significant investigations; abnormal renal function
  • Childbearing and breast-feeding women
  • Patients with history of allergic reaction to any angiotensin II antagonist

结局指标

主要结局

quality of life questionnaire for hypertension

时间窗: up to 1 month

medication satisfaction questionnaire

时间窗: up to 8 weeks

次要结局

  • Drug compliance questionnaire(up to 8 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验